Get Started

DMAC

NASD DiaMedica Therapeutics Inc.
Nov 4, 2026 · 1:59 PM ET DELAYED Market Open

$10.69 ↑ +0.69 (+6.90%) Trading Up from the previous close of $10.00, $0.31 below the day’s high of $11.00

YTD change
+34.30%
vs 20-day SMA
+24.66%
vs 200-day SMA
+50.02%

Price ranges

Previous day
$9.38 $10.04
open $9.38 close $10.00
+$0.62 (+6.61%)
Today
$10.15 $11.00
open $10.15 now $10.69
+$0.54 (+5.32%)
Past week
$8.60 $10.13
from $8.69 now $10.69
+$2.00 (+23.01%)
Past month
$7.53 $10.13
from $8.13 now $10.69
+$2.56 (+31.49%)
This year
$5.25 $11.00
from $7.96 now $10.69
+$2.73 (+34.30%)

Price & Performance

+3.95 (+65.29%) / 6M

$4.96$6.76$8.57$10.37May 4Aug 4Nov 3

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 1.7% away from all-time highs of $10.88
  • DMAC is up 34% since the beginning of the year
  • DMAC is up 59% over the past 12 months
  • DMAC is up 31% over the past 1 month
  • 14% of all DMAC investors are betting against DMAC

DMAC reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +49.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.19
Earnings momentum +8.4% Quarterly EPS growth
Quarterly change +8.4%

Valuation

P/E ratio N/A
Enterprise value $495.6M
Beta 1.36

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$43.5M
Debt$185.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $576.5M

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $461.26 -0.90%
MRNA Moderna, Inc. $228.44 +3.45%
RVMD Revolution Medicines, Inc. $194.23 +3.22%
ROIV Roivant Sciences Ltd. $36.04 +0.42%
BNTX BioNTech SE Sponsored ADR $86.92 -0.70%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.